Hi Neil, can you please ask management to provide some details of the 3.7 million licence fee. It is reported in the P&L, but I can’t see this amount being receipted in cash at bank or booked as a receivable in the balance sheet.
however, thiis number is shown in the reconciliation of cash as a non cash item?
Thanks.
Z
- Forums
- ASX - By Stock
- CGB
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-49
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online